Results
Johnson & Johnson Q1 Beats Guidance Raise
Johnson & Johnson reported Q1 2026 adjusted EPS $2.70, beating consensus $2.68, and revenue $24.1bn, up 9.9% YoY.
Company raised full‑year 2026 guidance to $11.45‑$11.65 EPS and $100.3‑$101.3bn sales,
